港股異動 | 鷹美(2368.HK)漲超4%創歷史新高 中期純利同比增長45.1%
格隆匯11月12日丨鷹美(2368.HK)午後直線拉昇,盤中高見4.11港元創歷史新高,現報4.02港元,漲4.15%,最新總市值21億港元。鷹美今日午間公佈截至9月30日止6個月業績稱,期內實現營收19.24億港元,同比增長1.7%;毛利4.32億港元,同比增長19.5%,毛利率由上年同期的19.1%升至22.5%;公司擁有人應占溢利2.31億港元,同比增長45.1%;每股基本盈利43.39港仙,宣派中期股息每股30港仙。公告還稱,集團抓緊機遇,積極爭取國內的中高端運動服飾的訂單,為集團在全球經濟不明朗的情況下增加了動力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.